Browse by Person
 | Up a level |
14 January 2021
Shyam, M. and Shilkar, D. and Verma, H. and Dev, A. and Sinha, B. and Brucoli, F. and Bhakta, Sanjib and Jayaprakash, V. (2021) The Mycobactin biosynthesis pathway: a prospective therapeutic target in the battle against Tuberculosis. Journal of Medicinal Chemistry 64 (1), pp. 71-100. ISSN 0022-2623.
13 January 2022
Shyam, M. and Verma, H. and Bhattacharje, G. and Mukherjee, P. and Singh, S. and Kamilya, S. and Jalani, P. and Das, S. and Dasgupta, A. and Mondal, A. and Das, A.K. and Singh, A. and Brucoli, F. and Bagneris, Claire and Dickman, R. and Basavanakatti, V.N. and Naresh Babu, P. and Sankaran, V. and Dev, A. and Sinha, B.N. and Bhakta, Sanjib and Jayaprakash, V. (2022) Mycobactin analogues with excellent pharmacokinetic profile demonstrate potent antitubercular specific activity and exceptional efflux pump inhibition. Journal of Medicinal Chemistry 65 (1), pp. 234-256. ISSN 0022-2623.
15 December 2023
Shyam, M. and Bhattacharje, G. and Daniel, C. and Kumar, A. and Yadav, P. and Mukherjee, P. and Singh, S. and Das, A.K. and Narender, T. and Singh, A. and Jayaprakash, V. and Bhakta, Sanjib (2023) Rationally designed novel Phenyloxazoline Synthase Inhibitors: chemical synthesis and biological evaluation to accelerate the discovery of new antimycobacterial antibiotics. Molecules 28 (24), p. 8115. ISSN 1420-3049.